Effects of polymorphisms in nucleotide-binding oligomerization domains 1 and 2 on biomarkers of the metabolic syndrome and type II diabetes

详细信息    查看全文

• 作者：Cristina Cuda (1)
  Alaa Badawi (2)
  Mohamed Karmali (1) (2)
  Ahmed El-Sohemy (1)
  
• 关键词：Nucleotide oligomerization domains ; Innate immunity ; Insulin sensitivity ; Saturated fat
• 刊名：Genes & Nutrition
• 出版年：2012
• 出版时间：July 2012
• 年：2012
• 卷：7
• 期：3
• 页码：427-435
• 全文大小：261KB
• 参考文献：1. Abbott DW, Wilkins A, Asara JM, Cantley LC (2004) The Crohn’s disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr Biol 200414:2217-227 CrossRef
  2. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr, Montoye HJ, Sallis JF, Paffenbarger RS Jr (1993) Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25:71-0 CrossRef
  3. Ascaso JF, Pardo S, Real JT, Lorent RI, Priego A, Carmena R (2003) Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diab Care 26:3320-325 CrossRef
  4. Badawi A, Klip A, Haddad P, Cole DE, Garcia-Bailo B, El-Sohemy A, Karmali M (2010) Type 2 diabetes mellitus and inflammation: prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes 3:173-86 CrossRef
  5. Cahill LE, Fontaine-Bisson B, El-Sohemy A (2009) Functional genetic variants of glutathione S-transferase protect against serum ascorbic acid deficiency. Am J Clin Nutr 90:1411-417 CrossRef
  6. Chamaillard M, Girardin SE, Viala J, Philpott DJ (2003) Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol 5:581-92 CrossRef
  7. Chavez JA, Summers SA (2003) Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 419:101-09 CrossRef
  8. Clandinin MT, Cheema S, Field CJ, Garg ML, Venkatraman J, Clandinin TR (1991) Dietary fat: exogenous determination of membrane structure and cell function. FASEB J 5:2761-769
  9. Dharancy S, Body-Malapel M, Louvet A, Berrebi D, Gantier E, Gosset P, Viala J, Hollebecque A, Moreno C, Philpott DJ, Girardin SE, Sansonetti PJ, Desreumaux P, Mathurin P, Dubuquoy L (2009) Neutrophil migration during liver injury is under nucleotide-binding oligomerization domain 1 control. Gastroenterology 138:1546-556 CrossRef
  10. Entrez SNP (2011) Accessed on: 24 Oct, 2011. Available at: http://www.ncbi.nlm.nih.gov/snp
  11. Eny KM, Wolever TM, Fontaine-Bisson B, El-Sohemy A (2008) Genetic variant in the glucose transporter type 2 is associated with higher intakes of sugars in two distinct populations. Physiol Genomics 33:355-60 CrossRef
  12. Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, Josse RG, Leiter LA, Rodger NW, Ryan EA, Connelly PW, Corey PN, El-Sohemy A (2007) Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations. Am J Clin Nutr 86:768-74
  13. Fontaine-Bisson B, Wolever TM, Connelly PW, Corey PN, El-Sohemy A (2009) NF-kappaB -94Ins/Del ATTG polymorphism modifies the association between dietary polyunsaturated fatty acids and HDL-cholesterol in two distinct populations. Atherosclerosis 204:465-70 CrossRef
  14. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jehanno M, Viala J, Tedin K, Taha MK, Labigne A, Zahringer U, Coyle AJ, DiStefano PS, Bertin J, Sansonetti PJ, Philpott DJ (2003a) Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:1584-587 CrossRef
  15. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ (2003b) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278:8869-872 CrossRef
  16. Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, Podolsky DK (2003) CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124:993-000 CrossRef
  17. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599-03 CrossRef
  18. Hysi P, Kabesch M, Moffatt MF, Schedel M, Carr D, Zhang Y, Boardman B, von Mutius E, Weiland SK, Leupold W, Fritzsch C, Klopp N, Musk AW, James A, Nunez G, Inohara N, Cookson WO (2005) NOD1 variation, immunoglobulin E and asthma. Hum Mol Genet 14:935-41 CrossRef
  19. Inohara N, Nunez G (2003) NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 3:371-82 CrossRef
  20. Inohara N, Koseki T, del Peso L, Hu Y, Yee C, Chen S, Carrio R, Merino J, Liu D, Ni J, Nunez G (1999) Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J Biol Chem 274:14560-4567 CrossRef
  21. Inohara N, Koseki T, Lin J, del Peso L, Lucas PC, Chen FF, Ogura Y, Nunez G (2000) An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J Biol Chem 275:27823-7831
  22. Jove M, Planavila A, Laguna JC, Vazquez-Carrera M (2005) Palmitate-induced interleukin 6 production is mediated by protein kinase C and nuclear-factor kappaB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells. Endocrinology 146:3087-095 CrossRef
  23. Jove M, Planavila A, Sanchez RM, Merlos M, Laguna JC, Vazquez-Carrera M (2006) Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation. Endocrinology 147:552-61 CrossRef
  24. Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, Fuji A, Yuasa T, Manki A, Sakurai Y, Nakajima M, Kobayashi H, Fujiwara I, Tsutsumi H, Utani A, Nishigori C, Heike T, Nakahata T, Miyachi Y (2005) Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105:1195-197 CrossRef
  25. Lee JY, Ye J, Gao Z, Youn HS, Lee WH, Zhao L, Sizemore N, Hwang DH (2003) Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J Biol Chem 278:37041-7051 CrossRef
  26. Lee JS, Pinnamaneni SK, Eo SJ, Cho IH, Pyo JH, Kim CK, Sinclair AJ, Febbraio MA, Watt MJ (2006) Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol 100:1467-474 CrossRef
  27. Manco M, Mingrone G, Greco AV, Capristo E, Gniuli D, De Gaetano A, Gasbarrini G (2000) Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism 49:220-24 CrossRef
  28. Mann JI (2006) Evidence-based nutrition recommendations for the treatment and prevention of type 2 diabetes and the metabolic syndrome. Food Nutr Bull 27:161-66
  29. Maron DJ, Fair JM, Haskell WL (1991) Saturated fat intake and insulin resistance in men with coronary artery disease. The Stanford Coronary Risk Intervention Project Investigators and Staff. Circulation 84:2020-027 CrossRef
  30. McGovern DPB, Hysi P, Ahmad T, van Heel DA, Moffat MF, Carey A, Cookson WOC, Jewell DP (2005) Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 14:1245-250 CrossRef
  31. Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, Chamaillard M, Zouali H, Thomas G, Hugot JP (2001) CARD15 mutations in Blau syndrome. Nat Genet 29:19-0 CrossRef
  32. Montell E, Turini M, Marotta M, Roberts M, Noe V, Ciudad CJ, Mace K, Gomez-Foix AM (2001) DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells. Am J Physiol Endocrinol Metab 280:E229–E237
  33. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G (2001a) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603-06 CrossRef
  34. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G (2001b) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276:4812-818 CrossRef
  35. Paffenbarger RS Jr, Blair SN, Lee IM, Hyde RT (1993) Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc 25:60-0 CrossRef
  36. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH (1997) Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983-88 CrossRef
  37. Parker DR, Weiss ST, Troisi R, Cassano PA, Vokonas PS, Landsberg L (1993) Relationship of dietary saturated fatty acids and body habitus to serum insulin concentrations: the Normative Aging Study. Am J Clin Nutr 58:129-36
  38. Peeters MW, Thomis MA, Loos RJ, Derom CA, Fegard R, Vlietinck RF, Beunen GP (2008) Clustering of metabolic risk factors in young adults: genes and environment. Atherosclerosis 200:168-76 CrossRef
  39. Pradhan A (2007) Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders. Nutr Rev 65:S152–S156 CrossRef
  40. Radin MS, Sinha S, Bhatt BA, Dedousis N, O’Doherty RM (2008) Inhibition or deletion of the lipopolysaccharide receptor Toll-like receptor-4 confers partial protection against lipid-induced insulin resistance in rodent skeletal muscle. Diabetologia 51:336-46 CrossRef
  41. Rosenstiel P, Fantini M, Brautigam K et al (2003) TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124:1001-009 CrossRef
  42. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116:3015-025 CrossRef
  43. Song Y, Mason J, TInker L, Howard BV, Kuller LH, Nathan L, Rifai N, Liu N (2007) Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women. Diab Care 30:1747-752 CrossRef
  44. Tada H, Aiba S, Shibata K, Ohteki T, Takada H (2005) Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect Immun 73:7967-976 CrossRef
  45. Takahashi Y, Isuzugawa K, Murase Y, Imai M, Yamamoto S, Iizuka M, Akira S, Bahr GM, Momotani E, Hori M, Ozaki H, Imakawa K (2006) Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages. J Vet Med Sci 68:471-78 CrossRef
  46. Tierney AC, McMonagle J, Shaw DI, Gulseth HL, Helal O, Saris WH, Paniagua JA, Golabek-Leszczy?ska I, Defoort C, Williams CM, Karsltr?m B, Vessby B, Dembinska-Kiec A, López-Miranda J, Blaak EE, Drevon CA, Gibney MJ, Lovegove JA, Roche HM (2011) Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome–LIPGENE: a European randomized dietary intervention study. Int J Obes (Lond) 35(6):800-09 CrossRef
  47. Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, Araujo EP, Vassallo J, Curi R, Velloso LA, Saad MJ (2007) Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56:1986-998 CrossRef
  48. Weidinger S, Klopp N, Rummler L, Wagenpfeil S, Novak N, Baurecht HJ, Groer W, Darsow U, Heinrich J, Gauger A, Schafer T, Jakob T, Behrendt H, Wichmann HE, Ring J, Illig T (2005) Association of NOD1 polymorphisms with atopic eczema and related phenotypes. J Allergy Clin Immunol 116:177-84 CrossRef
  49. Wellen KE, Hotamisligil GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115:1111-119
  50. Willet W (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, New York CrossRef
  51. Zhao L, Kwon MJ, Huang S, Lee JY, Fukase K, Inohara N, Hwang DH (2007) Differential modulation of Nods signaling pathways by fatty acids in human colonic epithelial HCT116 cells. J Biol Chem 282:11618-1628 CrossRef
  
• 作者单位：Cristina Cuda (1)
  Alaa Badawi (2)
  Mohamed Karmali (1) (2)
  Ahmed El-Sohemy (1)
  
  1. Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, 150 College Street, Room 350, Toronto, ON, M5S 3E2, Canada
  2. Office of Biotechnology, Genomics and Population Health, Public Health Agency of Canada, Toronto, ON, Canada
  
• ISSN：1865-3499

文摘

The innate immune receptor toll-like receptor 4 (TLR4) has been implicated in mediating some of the effects of dietary lipids on inflammation and type 2 diabetes (T2D). Similar to TLR4, the nucleotide-binding oligomerization domains (Nods) 1 and 2 are also proteins of innate immunity, which can respond to lipids and initiate pro-inflammatory signalling that plays a role in the aetiology of T2D. The objective was to determine the effect of Nod1 (Glu266Lys) and Nod2 (Ser268Pro) genotypes on factors associated with the metabolic syndrome (MetS), and whether they modify the association between dietary lipids and biomarkers of the MetS. Men and women (n?=?998) between the ages of 20-9?years were genotyped for both polymorphisms, completed a one-month, semiquantitative food frequency questionnaire and provided a fasting blood sample. The Glu266Lys polymorphism in Nod1 was not associated with any of the biomarkers of the MetS, but modified the association between dietary saturated fat (SFA) and insulin sensitivity, as measured by HOMA-IR (p for interaction?=?0.04). Individuals with the Glu/Glu or Glu/Lys genotype showed no significant relationship between dietary SFA and HOMA-IR (β?=??.002?±?0.006, p?=?0.77; and β?=??.003?±?0.006, p?=?0.61), while those with the Lys/Lys genotype showed a positive association (β?=?0.033?±?0.02, p?=?0.03). The Nod2 Ser268Pro polymorphism was not associated with components of the MetS and did not modify the relationship between dietary lipid intake and the biomarkers of MetS. In summary, the Nod1 Glu266Lys polymorphism modifies the relationship between dietary SFA intake and HOMA-IR, suggesting that Nod1 may act as an intracellular lipid sensor affecting insulin sensitivity.